BPG is committed to discovery and dissemination of knowledge
Letter to the Editor
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Nephrol. Sep 25, 2025; 14(3): 107879
Published online Sep 25, 2025. doi: 10.5527/wjn.v14.i3.107879
Modified National Early Warning Score 2, warning system for predicting treatment outcomes in patients with emphysematous pyelonephritis
Mohammad S Al-Haggar, Zahraa A Abdelmoneim
Mohammad S Al-Haggar, Zahraa A Abdelmoneim, Department of Pediatrics, Genetics and Metabolic Unit, Mansoura University Children’s Hospital, Mansoura 35516, Egypt
Author contributions: Al-Haggar MS revised the manuscript; Abdelmoneim ZA wrote the manuscript.
Conflict-of-interest statement: All authors declare that they have no conflict of interest to disclose.
Corresponding author: Zahraa A Abdelmoneim, MD, Lecturer, Department of Pediatrics, Genetics and Metabolic Unit, Mansoura University Children’s Hospital, EL Gomhoria Street, Mansoura 35516, Egypt. hzahraa211@gmail.com
Received: April 2, 2025
Revised: May 20, 2025
Accepted: September 2, 2025
Published online: September 25, 2025
Processing time: 168 Days and 23.1 Hours
Core Tip

Core Tip: Emphysematous pyelonephritis (EPN) is a life-threatening necrotizing infection of the upper urinary tract, predominantly affecting individuals with diabetes mellitus. Early diagnosis and severity assessment are critical due to its high mortality rate. This study proposes a modified National Early Warning Score 2 (mNEWS 2) to enhance risk stratification and predictive accuracy in EPN management. By refining physiological parameter thresholds and incorporating weighted risk indices, mNEWS 2 improves triaging, prioritizes intensive monitoring, and facilitates timely interventions. Validated through receiver operating characteristic curve analysis, the mNEWS 2 score, particularly at a cutoff of 15, maximizes predictive performance for mortality risk and intervention needs.